Patent details

Basic Information

Publication number:

EP2450442

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP121530265

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS AND METHODS OF USING CHONDROITINASE ABCI MUTANTS

French Title of Invention:

COMPOSITIONS ET PROCÉDÉS D'UTILISATION DE MUTANTS DES CHONDROÏTINASE ABCI

German Title of Invention:

ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON CHONDROITINASE-ABCI-MUTANTEN

SPC Number:

Dates

Filing date:

10/10/2007

Grant date:

19/07/2017

EP Publication Date:

09/05/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/07/2017

EP B1 Publication Date:

19/07/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/10/2017

Expiration date:

10/10/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/07/2017

 

 

Name:

Acorda Therapeutics, Inc.

Address:

420 Saw Mill River Road, Ardsley, NY 10502, United States (US)

Inventor

1

Name:

Vecchione, Andrea

Address:

United States (US)

2

Name:

Iaci, Jennifer

Address:

United States (US)

3

Name:

Caggiano, Anthony O.

Address:

United States (US)

Priority

Priority Number:

828800 P

Priority Date:

10/10/2006

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/51; C12N 9/88; C12N 15/60;

Publication

European Patent Bulletin

Issue number:

201729

Publication date:

19/07/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2018	Outgoing Correspondence	1